Nathan B. Fountain - Jul 6, 2021 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Katherine Denby, Attorney-in-Fact
Stock symbol
ABOS
Transactions as of
Jul 6, 2021
Transactions value $
$100,000
Form type
4
Date filed
7/8/2021, 06:13 PM
Previous filing
Jun 30, 2021
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABOS Common Stock Purchase $100K +6.25K $16.00 6.25K Jul 6, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.